Ligand Pharmaceuticals IncorporatedLGNDNASDAQ
Loading
Net Income ScalingExpanding
Percentile Rank79
Studio
Year-over-Year Change

Total earnings after all expenses, taxes, and interest

Percentile
P79
Within normal range
vs 2Y Ago
2.4x
Strong expansion
Streak
1 yr
Consecutive growthExpanding
PeriodValueYoY Change
TTM$124.45M+3186.6%
2024$-4.03M-107.7%
2023$52.15M+256.3%
2022$-33.36M-158.4%
2021$57.14M+2014.2%
2020$-2.98M-100.5%
2019$629.30M+339.1%
2018$143.32M+1041.5%
2017$12.56M+867.5%
2016$-1.64M-